TXG logo

10X Genomics Inc (TXG)

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as...

NASDAQHealthcareMedical DevicesUSA

Company Profile

Stock Code
TXG
ISIN Code
US88025U1097
Currency
US Dollar (USD)
IPO Date
2019-09-12

Contact Information

Company Address
6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
Contact Phone
925 401 7300
Company Website
https://www.10xgenomics.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-5.05%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99